As one of the main holders of the Mediterranean Diet, Italy is rich in raw materials that can be used to benefit the human health. Our research is focused on the study of ingredients of Mediterranean origin to create a culture of prevention for today and future generations. All our processes, from research to production and marketing, are located in Italy and aim to reduce our impact on the planet and support local farmers and producers. We use a pharmaceutical approach to our nutraceutical production, delivering on the market only products that benefit of an extended research and clinical studies, we call this approach Nutrac-Etico®. We promote only on professional targets in Italy, supported by our Nutra Advisor team, experts in nutraceutical and nutrition. We are building a global presence through reliable partners in EU and non-Eu countries. Our vision is to contribute to a healthy society in a healthy planet.
| Website | http://www.esserrepharma.com |
| Revenue | $5.7 million |
| Employees | 58 (33 on RocketReach) |
| Founded | 2013 |
| Phone | +39 06 3973 6623 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Mediterranean Diet, Pharmaceutical Research, Natural Ingredients, Scientific Research, Nutraceutical Products, Functional Foods, Plant Extracts, Dietary Supplements, Health Supplements, Ingredient Sourcing, Prevention, Herbal Remedies, Food Supplements, Quality Control, Wellness Products, Manufacturing, Healthy Aging, Distribution, Export, Import |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck AH, AbbVie, Pfizer, Sanofi, Bayer, GSK, AstraZeneca +53 more (view full list) |
Looking for a particular ESSERRE PHARMA employee's phone or email?
The ESSERRE PHARMA annual revenue was $5.7 million in 2026.
Amedeo Squillace is the CEO of ESSERRE PHARMA.
33 people are employed at ESSERRE PHARMA.